drugset / Trial / NCT00694915

Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder

NCT00694915 ↗

Phase 2 Completed 122 enrolled Cadila Pharnmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine and compare the effect of this treatment on recurrence rate and to assess the toxicity in both arms of patients with STCC. Other objectives include determining the effects of this treatment on quality of life, and comparing the effect of Mycobacterium w on time to tumor progression.

Timeline

Start
2008-08-28
Primary completion
2014-03-31
Completion
2015-10-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator BCG Unknown — —
Subject Mycobacterium w Vaccine — —